STEMI reperfusion timing, persistent symptoms after pulmonary embolism and safer ward care for young people in mental health crisis shape today’s briefing.
Successful thrombolysis does not end the STEMI pathway; transfer to a PCI-capable centre and plan angiography within 2–24 hours.
The acute-care material covers paediatric mental health safety and STEMI reperfusion. Young people awaiting specialist mental health care on general paediatric wards need repeated structured risk checks, environmental modification, active therapeutic observation and clear escalation routes. The same paediatric update highlights targeted cast safety-netting after manipulation of distal both-bone forearm fractures. The STEMI episode links symptom onset and a 120-minute primary PCI delay threshold to fibrinolysis, followed by reassessment at 60–90 minutes, transfer after successful lysis and urgent catheter-laboratory care when cardiogenic shock develops.
Cardiorespiratory follow-up includes persistent symptoms after pulmonary embolism and cardiac causes of exertional breathlessness. Dyspnoea, fatigue or exercise limitation beyond three months after pulmonary embolism should prompt structured reassessment rather than reassurance alone. V/Q imaging, echocardiography, respiratory testing and functional assessment help distinguish post-PE impairment, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension. Breathlessness that has not responded to respiratory treatment should also trigger review for angina, heart failure, valvular disease, arrhythmia or congenital shunt.
The remaining clinical material spans glucocorticoid physiology and safe withdrawal, sex-specific psychopharmacology, ME/CFS with post-exertional malaise and pacing, and early multidisciplinary care for cleft lip and palate. Photic sneezing adds a neurological and ophthalmic reflex topic, while the simulation episode examines how human factors and scenario testing can support safer clinical innovation.
Paediatric, psychiatry and emergency teams get a ward-safety update for young people awaiting specialist mental health care. Repeated structured checks, environmental risk reduction, therapeutic one-to-one observation and escalation sit alongside targeted safety-netting for reduced distal both-bone forearm fractures and cautious interpretation of toxic-ingestion data.
Cardiology, respiratory and acute medicine teams get a structured approach to persistent symptoms after pulmonary embolism. It differentiates post-PE impairment, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension, linking follow-up to symptom scoring, V/Q imaging, echocardiography, functional assessment and individualised anticoagulation decisions.
An acute STEMI pathway update for emergency, cardiology and acute medicine teams. It connects symptom onset and expected primary PCI delay with fibrinolysis, reassessment at 60–90 minutes, rescue PCI, angiography within 2–24 hours after successful lysis and immediate invasive management for cardiogenic shock.
A physiology and prescribing refresher for clinicians using hydrocortisone, prednisolone or dexamethasone. HPA-axis regulation, intracellular receptor effects, adrenal suppression, hyperglycaemia, infection, bone risk and safe withdrawal after prolonged systemic treatment are kept together.
Progressive exertional breathlessness needs timing, threshold and reproducibility defined before assuming airways disease or interstitial lung disease. This is strong revision for drug exposure, past jobs, home mould, birds, hobbies and persistent symptoms after pulmonary embolism.
Medical educators and human-factors teams get a systems-focused discussion of simulation as a testbed for devices, workflows and service redesign. Translational simulation, simulated participants, rapport, telehealth, community care, AI-enabled workflows and measurable outcomes are framed as tools for safer implementation.
Psychiatry, obstetrics and gynaecology, and endocrinology clinicians get sex-specific prescribing considerations. Valproate’s fetal and endocrine risks, lower zolpidem dose limits, atypical depression, premenstrual symptom changes, pregnancy and breastfeeding are central to the discussion.
A concise explanation of bright-light-triggered sneezing, also known as the photic sneeze reflex or ACHOO syndrome. It covers optic-trigeminal pathways, heritability and implications during ophthalmic examination or safety-critical work.
A general-practice and neurology review of ME/CFS centred on acquired functional decline and post-exertional malaise. It distinguishes delayed symptom crashes from ordinary fatigue, addresses orthostatic intolerance and diagnostic mimics, and supports pacing, adaptation, comorbidity treatment and cautious off-label prescribing.
Paediatric and ENT teams get an overview of cleft lip and palate, with early priorities around feeding, swallowing and specialist cleft-service referral. It also covers surgical timing, speech, hearing, dental development and psychosocial follow-up.
In suspected STEMI, document symptom onset, ECG findings, pain, contraindications and expected primary PCI delay before handover. When primary PCI cannot be delivered within 120 minutes and presentation is within 12 hours without contraindications, discuss fibrinolysis promptly. Reassess symptoms and ST-segment resolution at 60–90 minutes, then transfer after lysis even when reperfusion appears successful.
A patient presents eight hours after STEMI symptom onset, has no contraindication to fibrinolysis and faces a 180-minute transfer for primary PCI. What reperfusion strategy is indicated?
Intravenous fibrinolysis is indicated because primary PCI cannot be delivered within 120 minutes and presentation is within the 12-hour treatment window.
What findings at 60–90 minutes support successful fibrinolysis, and what should happen next?
Pain resolution with more than 50% improvement in ST-segment elevation supports successful fibrinolysis. The patient still requires immediate transfer to a PCI-capable centre, with angiography planned within 2–24 hours if stable.
A patient remains breathless after pulmonary embolism, with residual perfusion defects but no pulmonary hypertension at rest. What is the most appropriate clinical label?
Chronic thromboembolic disease. Chronic thromboembolic pulmonary hypertension requires pulmonary hypertension at rest.
.svg)